Clinical application of the neonatal early-onset sepsis risk assessment calculator

Abstract

Neonatal sepsis is divided into early-onset sepsis (EOS) and late-onset sepsis (LOS). The European neonatal detection network reported in 2011 that EOS has a high mortality rate of 26.3%, almost double that of LOS (13.3%). EOS sometimes lacks specific symptoms, which makes early diagnosis difficult and leads to extensive empirical antibiotic therapy with potential hazards and both immediate and long-term adverse outcomes. The Neonatal EOS Risk Calculator is an assessment model proposed in recent years to quantify the risk of EOS in newborns based on a range of high-risk factors in the perinatal period. This model has attracted widespread attention in some developed countries and has been applied in retrospective and prospective clinical studies, suggesting new strategies to address the appropriate use of antibiotics in neonates. This article reviews the clinical application and research progress of the Neonatal EOS Risk Calculator.

Keywords

Early-onset sepsis in neonates / EOS risk assessment calculator / Clinical application

References

[1] Hunan Neonatal Medical Quality Control Center, Neonatology Group of Perinatal Committee of Hunan Medical Association. Recommendations on the diagnosis and the use of antibiotics for early-onset sepsis in preterm infant:consensus of the expert panel from Hunan Province[J]. Chin J Contemp Pediatr. 2020; 22 (1): 1- 6.

[2] Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of pediatric and neonatal sepsis:a systematic review[J]. Lancet Respir Med. 2018; 6 (3): 223- 230.

[3] Oza S, Lawn JE, Hogan DR, et al. Neonatal cause-of-death estimates for the early and late neonatal periods for 194 countries:2000-2013[J]. Bull World Health Organ. 2015; 93: 19- 28.

[4] Polin RA. Management of neonates with suspected or proven early-onset bacterial sepsis[J]. Pediatrics. 2012; 129 (5): 1006- 10015.

[5] Schuchat A, Zywicki SS, Dinsmoor MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis:a multicenter case-control study[J]. Pediatrics. 2000; 105 (1): 21- 26.

[6] Martius JA, Roos T, Gora B, et al. Risk factors associated with early-onset sepsis in premature infants[J]. Eur J Obstet Gynecol Reprod Biol. 1999; 85 (2): 151- 158.

[7] Liu ZJ, Chen X, Li J, et al. Factors influencing intestinal bacterial colonization and antibiotic resistance in early neonates in neonatal intensive care units[J]. Chinese Journal of Neonatology. 2020; 35 (2): 118- 122.

[8] Esaiassen E, Fjalstad JW, Juvet LK, et al. Antibiotic exposure in neonates and early adverse outcomes:a systematic review and meta-analysis[J]. J Antimicrob Chemother. 2017; 72 (7): 1858- 1870.

[9] Mitre E, Susi A, Kropp LE, et al. Association between acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood[J]. JAMA Pediatr. 2018;172(6), e180315.

[10] Mukhopadhyay S, Puopolo KM, Hansen NI, et al. Impact of early-onset sepsis and antibiotic use on death or survival with neurodevelopmental impairment among extremely preterm infants at two years of age among extremely preterm infants[J]. J Pediatr. 2020; 221: 39- 46.e5.

[11] Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns≥34 weeks' gestation[J]. Pediatrics. 2014; 133 (1): 30- 36.

[12] Puopolo KM, Lynfield R, Cummings JJ. Management of infants at risk for group B Streptococcal disease[J]. Pediatrics. 2019;144(2), e20191881.

[13] Kuzniewicz MW, Walsh EM, Li S, et al. Developing and implementing an early-onset sepsis calculator to guide antibiotic management in late preterm and term neonates [J]. Joint Comm J Qual Patient Saf. 2016; 42 (5): 232- 239.

[14] Kuzniewicz MW, Puopolo KM, Fischer A, et al. A Quantitative,Risk-based approach to the management of neonatal early-onset sepsis[J]. JAMA Pediatr. 2017; 171 (4): 365- 371.

[15] Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns≥34 weeks' gestation[J]. Pediatrics. 2014; 133 (1): 30- 36.

[16] Puopolo KM, Draper D, Wi S, et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors[J]. Pediatrics. 2011; 128 (5): e1155- e1163.

[17] Carola D, Vasconcellos M, Sloane A, et al. Utility of early-onset sepsis risk calculator for neonates born to mothers with Chorioamnionitis[J]. J Pediatr. 2018; 195: 48- 52. e1.

[18] He Y, Chen J, Liu Z, et al. Efficacy and safety of applying a neonatal early-onset sepsis risk calculator in China[J]. J Paediatr Child Health. 2020; 56 (2): 237- 243.

[19] Morris R, Jones S, Banerjee S, et al. Comparison of the management recommendations of the Kaiser Permanente neonatal early-onset sepsis risk calculator(SRC) with NICE guideline CG149 in infants≥34weeks' gestation who developed early-onset sepsis[J]. Arch Dis Child Fetal Neonatal Ed. 2020; 105 (6): 581- 586.

[20] Achten NB, Klingenberg C, Benitz WE, et al. Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety:a systematic review and meta-analysis[J]. JAMA Pediatr. 2019; 173 (11): 1032- 1040.

[21] Achten NB, Dorigo Zetsma JW, Van Der Linden PD, et al. Sepsis calculator implementation reduces empiric antibiotics for suspected early onset sepsis[J]. Eur J Pediatr. 2018; 177 (5): 741- 746.

[22] ZhangJ , Gao SQ, et al. Retrospective study to evaluate the performance of early onset sepsis calculator in neonates born to mothers with clinical chorioamnionitis[J]. Journal Developmental Medicine(Electronic Version). 2021; 9 (3): 182- 187.

[23] Zhu KZ, WangY , et al. Kasier sepsis risk calculator combined with the relevant clinical features for assessment of early-onset sepsis in neonates and its associated effects[J]. Anti Infect Pharm. 2020; 17 (7): 1018- 1020.

RIGHTS & PERMISSIONS

2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).